Ramsay researchers are advancing ME/CFS research and advocacy

SMCI is proud to have supported Fane Mensah (PhD candidate atUniversity College London, Ramsay 2016 Team 2 member) with a meetME Travel Award to facilitate collaboration with Chris Armstrong, a metabolomics expert at the University of Melbourne in Australia (currently a researcher at Stanford). As part of their Ramsay Research Award supported project with Dr. Geraldine (Jo) Cambridge (University College London), the team is examining links between immune cell functioning and their metabolic capacities in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) patients as compared to healthy controls. This cross-discipline work is a powerful integrative approach to address the complexity of ME/CFS. You can read the study abstract here and a midstream update from the team here.

In addition to working on their scientific collaboration, Mensah and Armstrong also met with Parliament to advocate for advances in biomedical research.

Mensah expressed that “we believe that it’s important for researchers to meet with politicians to educate and translate the advances of biomedical research in the field. The meetings were positive and it was apparent that they valued our visit and the information we provided. We will keep you updated on the developments, and we are thankful for your support.”

Pictured: Fane Mensah, Senator Helen Polley, and Chris Armstrong. Senator Polley represents Tasmania and has contributed to the Labor Party’s health policy strategy for elections.

The meetME Travel Awards support the participation of junior scientists and underrepresented groups in targeted meetings, conferences, and collaborative ventures focused on myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Through this award program, SMCI advances the twin goals of collaborative research and increased participation from new investigators in the ME/CFS field. The meetME Awards enable qualified scientists to broaden their perspective and knowledge, grow their research networks, and shape the direction of ME/CFS research and treatment discovery. Learn more here.